Skip to content

Dr. Matthieu Deruyttere

Active
Private limited companyfounded 2003active for 22 yearsHulstbaan 3, 9112 Sint-Niklaas, BelgiumKBO/BCE: BE 0861.652.186
Summary

Dr. Matthieu Deruyttere has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €939,153 and a net result of €144,802. Equity has been growing by about 11% per year since 2019. Its solvency ranks better than 56% of 419 sector peers (NACE 86, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 17-11-2003 Normal situation
Activity
General medical practice NACE 86210
Establishment units
2.229.082.368 9112 Sint-Niklaas, since 17-11-2003
2.338.985.348 9112 Sint-Niklaas, since 01-10-2022
Financial year end
31 March
Peppol
Reachable since 26-06-2025

Board and ownership

Board
  • Deruyttere MatthieuDirector

Financial position

94 Excellent Checked score 2026
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 31-03-2026
Gross margin
€255,183
▼ 3.6%
Turnover
≈ €390,000
estimated
Profit
€144,802
▼ 5.5%
Equity
€939,153
▼ 10.3%
Total assets
€1.2m
▲ 2.5%
Filed on 25-09-2026, 36 days before the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.87, cash €657,978Size: total assets €1.2mEquity €939,153 (76.9% of total assets)Show the evidence

Checked score

Score 2026
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 54% of micro companies in human health (NACE 86)
Financial strength · tick: 2025
Strong
Solvency 100=
equity 76.9% of total assets
Liquidity 92+9
short-term debt 23.1% · cash 53.9%
Profitability 84-1
return on assets 11.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025highest value 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €85,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.87 (5.1 in 2025), above the usual 1.5. Short-term debt is 23.1% and cash 53.9% of total assets. 23.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 77% on liquidity, 33% on profitability and 26% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.87, cash €657,978
NBB · annual accounts
lowers risk · Size: total assets €1.2m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €939,153 (76.9% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 25-09-2026, 36 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
36 days early
2025
56 days early
2024
42 days early
2023
32 days early
2022
41 days early
2021
44 days early
2020
39 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 41 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 20 September (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-03-2027 year end31-10-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 86% of companies in human healthsector median €182,648 · 419 companies €939,153 View
  • Positive: Filed on time since financial year 2019accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2026: €144,802 8 years View

Recent changes

  1. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as Dr. Matthieu Deruyttere: general medical practice (NACE 86210). They are comparable in size and age: total assets between €1.2m and €1.3m, founded between 2000 and 2006.

CompanyTotal assetsGross margin
Dr. Matthieu Deruyttere Sint-Niklaas€1.2m€0.3m
HUISARTSENPRAKTIJK BART MERCKX Sint-Niklaas€1.2m€0.2m
DOKTER SEGERS Wichelen€1.3m€0.3m
DOCTEUR PEPIN HUBERT Dour€1.3m€0.2m
Dr MORREN - VAN DEN BRANDE Mechelen€1.2m€0.3m
DOKTER BAERT Nieuwpoort€1.2m€0.3m
Dr. G. De Lendtdecker Antwerpen€1.2m€0.2m
Full comparison

Key facts about Dr. Matthieu Deruyttere

What is the company number of Dr. Matthieu Deruyttere?
The company number of Dr. Matthieu Deruyttere is 0861.652.186. The VAT number is the same number with BE in front: BE 0861.652.186.
Where is Dr. Matthieu Deruyttere based?
The registered office is at Hulstbaan 3, 9112 Sint-Niklaas.Company details
What does Dr. Matthieu Deruyttere do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Matthieu Deruyttere?
The legal form of Dr. Matthieu Deruyttere is Private limited company (BV).
When was Dr. Matthieu Deruyttere founded?
Dr. Matthieu Deruyttere was founded on 17-11-2003.
Is Dr. Matthieu Deruyttere still active?
Yes, Dr. Matthieu Deruyttere is an active enterprise in the KBO register.
How many employees does Dr. Matthieu Deruyttere have?
Dr. Matthieu Deruyttere had an average of 0.2 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
What is the turnover of Dr. Matthieu Deruyttere?
The turnover in financial year 2026 is ≈ €390,000. This figure is estimated from the gross margin of €255,183 and 36 comparable companies (NACE 862). It probably lies between €350,000 and €490,000.
Is Dr. Matthieu Deruyttere profitable?
In financial year 2026, Dr. Matthieu Deruyttere made a profit of €144,802.
Where can I find the annual accounts of Dr. Matthieu Deruyttere?
Dr. Matthieu Deruyttere filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of Dr. Matthieu Deruyttere due?
Dr. Matthieu Deruyttere must file the annual accounts for financial year 2027 by 31-10-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.